From six years spent at Starbucks to designing a new countertop coffeemaker that cranks out cold brew, Mesh Gelman has been working at the cutting edge of coffee.

During his time at Starbucks, he witnessed the rising popularity of cold beverages, a trend that his new startup, Cumulus Coffee Company, aims to capitalize on.

In this podcast episode, we talk with Gelman about coffee trends; developing a new product from scratch; the difference between big organizations and start-ups; and his past work as an innovation consultant.

In this episode, we catch up with Geoffrey Moore, the best-selling author, consultant, and venture capitalist whose groundbreaking work has shaped how we think about innovation strategy.

If you’ve ever talked about a technology "crossing the chasm" from the realm of early adopters into the early majority, or your company has put a high potential project into the incubation zone, you’ve been using language given to us by Moore. His best-selling books including Zone to Win, Inside the Tornado, and Crossing the Chasm — and lately, he’s been publishing a series of insightful LinkedIn articles on topics including the future of the office…rethinking personalization… and why it’s time to stop talking about generative AI and start doing something with it.

Listen to the episode to hear the full conversation. 

In this episode, we talk about the challenges of innovating in biopharma with a veteran of that industry, Dan Seewald. Seewald is the former Head of Worldwide Innovation at Pfizer, the $100 billion pharma giant headquartered in Manhattan, and now the founder and CEO of the consulting and training firm Deliberate Innovation. Among the questions that InnoLead CEO Scott Kirsner covers with Seewald:

• How do you create space for new ideas in a regulated industry?
• What's your advice on exploring the potential of AI? 
• How do you effectively communicate an internal innovation initiative?
• How do you deal with all of the legal and compliance colleagues who are very good at saying "no" to new ideas?
• What he'd do differently if he was starting over at Pfizer.

This episode was hosted by Scott Kirsner and edited by David Swope.